Category: biotech

.AstraZeneca has used artificial intelligence to design an one-of-a-kind biomarker for its Daiichi Sankyo-partnered datopotamab deruxtecan (Dato-DXd), wanting to separate the antibody-drug conjugate (ADC) coming

.AN2 Rehabs is rethinking its own business in response to poor midphase data, swearing to lay off half its own workers as well as quit

.ALX Oncology’s stage 2 gastric cancer cells feedback price has deteriorated. After finding its CD47 blocker simply beat management over the 1st half of the

.After much more than 20 years of deal with neurodegenerative conditions, Swiss biotech air conditioning Immune cases it might have a video game changer on